{"id":999004,"date":"2026-08-31T10:48:54","date_gmt":"2026-08-31T14:48:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/"},"modified":"2026-08-31T10:48:54","modified_gmt":"2026-08-31T14:48:54","slug":"aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/","title":{"rendered":"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ALISO VIEJO, Calif., Aug.  31, 2026  (GLOBE NEWSWIRE) &#8212; AEON Biopharma, Inc. (\u201cAEON\u201d or the \u201cCompany\u201d) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX<sup>\u00ae<\/sup> (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S. market entry, announced today that AEON management will host in-person 1&#215;1 investor meetings at Lake Street Capital Markets\u2019 10<sup>th<\/sup> Annual Best Ideas Growth (BIG10) Conference being held in New York City on Thursday, September 10<sup>th<\/sup>, 2026.<\/p>\n<p align=\"justify\">To receive additional information about the Conference, request an invitation or to schedule a one-on-one meeting, please contact your Lake Street Representative.<\/p>\n<p align=\"justify\">\n        <strong>About AEON Biopharma<\/strong>\n      <\/p>\n<p align=\"justify\">AEON Biopharma is a biopharmaceutical company pursuing full-label access to the U.S. therapeutic neurotoxin market via biosimilarity to BOTOX<sup>\u00ae<\/sup>. The U.S. therapeutic neurotoxin market exceeds $3.0 billion annually, representing a major opportunity for biosimilar entry. ABP-450 is the same botulinum toxin complex currently approved and marketed for cosmetic indications by Evolus, Inc. under the name Jeuveau<sup>\u00ae<\/sup>. ABP-450 is manufactured by Daewoong Pharmaceutical in a facility that has been authorized by the U.S. Food and Drug Administration, Health Canada, and European Medicines Agency for the manufacture of third-party botulinum toxin products. AEON has exclusive development and distribution rights for therapeutic indications of ABP-450 in the United States, Canada, the European Union, the United Kingdom, and certain other international territories. To learn more about AEON, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gci562-FJ9TaVAng-hZFoA_HCkxvtUuum1nA-iSyCtJMSCGT2c4b-4nI1IysLismhE9B6e962E7M1Nv1RYzs-8ZBu8twnICcavcpLS-PtWo=\" rel=\"nofollow\" target=\"_blank\">www.aeonbiopharma.com<\/a>.<\/p>\n<p>\n        <strong>Contacts <\/strong>\n      <\/p>\n<p>\n        <strong>Investor Contact: <\/strong><br \/>\n        <br \/>Hershel Berry<br \/>Blueprint Life Science Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Mkr_4aBMuUvLBjnqxbjNn1hQ7QEYic-OtsubQkeSdFZB-uc07_YbhXN5BZKB2Sxt__5P9QhJbgaOcYUw4thrtkMmKXZ_ArCgpHav4Wnc-gB6MROYGJDUSxp29FKj5QXp\" rel=\"nofollow\" target=\"_blank\">hberry@Bplifescience.com<\/a><\/p>\n<p>Source: AEON<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGMzNzFjZjgtNmM4OS00ZTliLWI0OWEtZGU2NzYyMWFmYjEzLTEyMzMzMzEtMjAyNi0wOC0zMS1lbg==\/tiny\/AEON-Biopharma-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALISO VIEJO, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) &#8212; AEON Biopharma, Inc. (\u201cAEON\u201d or the \u201cCompany\u201d) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX\u00ae (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S. market entry, announced today that AEON management will host in-person 1&#215;1 investor meetings at Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference being held in New York City on Thursday, September 10th, 2026. To receive additional information about the Conference, request an invitation or to schedule a one-on-one meeting, please contact your Lake Street Representative. About AEON Biopharma AEON Biopharma is a biopharmaceutical company pursuing full-label access to the U.S. therapeutic neurotoxin market via biosimilarity to BOTOX\u00ae. The U.S. therapeutic &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-999004","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ALISO VIEJO, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) &#8212; AEON Biopharma, Inc. (\u201cAEON\u201d or the \u201cCompany\u201d) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX\u00ae (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S. market entry, announced today that AEON management will host in-person 1&#215;1 investor meetings at Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference being held in New York City on Thursday, September 10th, 2026. To receive additional information about the Conference, request an invitation or to schedule a one-on-one meeting, please contact your Lake Street Representative. About AEON Biopharma AEON Biopharma is a biopharmaceutical company pursuing full-label access to the U.S. therapeutic neurotoxin market via biosimilarity to BOTOX\u00ae. The U.S. therapeutic &hellip; Continue reading &quot;AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-31T14:48:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference\",\"datePublished\":\"2026-08-31T14:48:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/\"},\"wordCount\":254,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/\",\"name\":\"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=\",\"datePublished\":\"2026-08-31T14:48:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/","og_locale":"en_US","og_type":"article","og_title":"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference - Market Newsdesk","og_description":"ALISO VIEJO, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) &#8212; AEON Biopharma, Inc. (\u201cAEON\u201d or the \u201cCompany\u201d) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 as a biosimilar to BOTOX\u00ae (onabotulinumtoxinA) for therapeutic use to achieve full-label U.S. market entry, announced today that AEON management will host in-person 1&#215;1 investor meetings at Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference being held in New York City on Thursday, September 10th, 2026. To receive additional information about the Conference, request an invitation or to schedule a one-on-one meeting, please contact your Lake Street Representative. About AEON Biopharma AEON Biopharma is a biopharmaceutical company pursuing full-label access to the U.S. therapeutic neurotoxin market via biosimilarity to BOTOX\u00ae. The U.S. therapeutic &hellip; Continue reading \"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-31T14:48:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference","datePublished":"2026-08-31T14:48:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/"},"wordCount":254,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/","name":"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=","datePublished":"2026-08-31T14:48:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgxODE2NiM3ODA5MjAzIzIyMjE3Nzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aeon-biopharma-to-participate-in-lake-street-capital-markets-10th-annual-best-ideas-growth-big10-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AEON Biopharma to Participate in Lake Street Capital Markets\u2019 10th Annual Best Ideas Growth (BIG10) Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=999004"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/999004\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=999004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=999004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=999004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}